Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Embla Medical hf Director's Dealing 2017

Feb 28, 2017

8210_rns_2017-02-28_d9ba0cf6-16b0-4475-bf05-0af63a827ead.html

Director's Dealing

Open in viewer

Opens in your device viewer

Ossur Hf : insider trading

Ossur Hf : insider trading

Announcement Össur hf. No. 17/2017
Reykjavík, 28 February 2017

Auðkenni útgefanda/Trade ticker:

OSSR

Nafn útgefanda/Issuer:

Össur hf.

Dagsetning tilkynningar/Date of announcement:

28 February 2017

Nafn fruminnherja/Name primary insider:

William Demant Invest A/S

Tengsl fruminnherja við útgefanda/Insider's relation with the issuer:

Niels Jacobsen

Dagsetning viðskipta/Date of transaction:

28 February 2017

Tímasetning viðskipta/Time of transaction:

16:03 CET

Tegund fjármálagernings/Type of financial instrument:

Equities

Kaup eða sala/Buy or Sell:

Buy

Fjöldi hluta/Number of shares:

2,000,000

Verð pr. Hlut/Price per share:

DKK 26.45

Fjöldi hluta í eigu fruminnherja eftir viðskipti/Primary insider's holdings
after the transaction:

190,960,514

Fjöldi hluta sem fruminnherji á kauprétt að/Primary insider's option holdings
after the transaction:

0

Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties'
holdings after the transaction:

0

Dagsetning lokauppgjörs*/Date of settlement*:

2 March 2017

Athugasemdir*/Comments*:

Niels Jacobsen is the chairman of the Össur Board of Directors.

[]